MicrobiologybioRxivPreprint
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy
A. M. Horspool, C. Ye, T. Y. Wong…·F. H. Damron
This study compares the pathogenicity and immune response of SARS-CoV-2 variants B.1.1.7 and B.1.351 with WA-1 in mice, showing reduced protection from convalescent plasma against the variants.
DOI 10.1101/2021.05.05.442784